Literature DB >> 15134811

Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models.

Damien Le Menuet1, Say Viengchareun, Martine Muffat-Joly, Maria-Christina Zennaro, Marc Lombès.   

Abstract

The human mineralocorticoid receptor (hMR), a ligand-dependent transcription factor (NR3C2) which belongs to the nuclear receptor superfamily, mediates most of the known effects of aldosterone. Beside its involvement in the regulation of sodium balance and the control of blood pressure, aldosterone-hMR tandem also exerts important regulatory functions on the cardiovascular and central nervous systems. To study the molecular mechanisms involved in the tissue-specific expression of hMR and explore its functional implication in pathophysiology, transgenic mouse models have been generated using both targeted oncogenesis and MR overexpression. We have previously demonstrated that the transcription of hMR is directed by two alternative promoters, P1 and P2, which correspond to the 5'-flanking regions of the untranslated exons 1alpha and 1beta of the hMR gene, respectively. Utilization of P1 and P2 to drive expression of the SV40 large T antigen (TAg) in transgenic mice led us (i) to determine distinct tissue-specific patterns of promoter usage; (ii) to identify novel sites of MR expression including brown adipose tissue, thus providing a new functional link between aldosterone and energy homeostasis; (iii) to generate original immortalized cell lines derived from numerous aldosterone-sensitive tissues most notably distal nephron, brown fat, skin, liver, lung, brain, heart, blood vessels and inner ear. These differentiated cell lines represent suitable models to further explore cell-specific mineralocorticoid responses and cross-talk with other signaling pathways. Generation of transgenic mice in which hMR expression was directed by P1 promoter demonstrated the importance of MR in the cardiac and renal function. Morphological and functional alterations of the renal tubule were observed with basal decreased sodium/potassium ratio exacerbated under sodium depletion. Hypokinetic dilated cardiomyopathies were associated with tachycardia, arrhythmia but normal arterial blood pressure emphasizing the direct role of MR on cardiomyocyte function. Taken together, transgenic animal models constitute valuable experimental systems to gain new insights into the widespread and pleiotropic in vivo functions of MR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134811     DOI: 10.1016/j.mce.2003.10.045

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

1.  Mineralocorticoid-receptor antagonists in heart failure: a tale of serendipity and success.

Authors:  Alex Reyentovich; Stuart D Katz
Journal:  Curr Heart Fail Rep       Date:  2011-06

Review 2.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 3.  Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.

Authors:  Andrew S Brem; Rujun Gong
Journal:  Clin Sci (Lond)       Date:  2015-05       Impact factor: 6.124

4.  Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Authors:  Peter Kamenicky; Say Viengchareun; Anne Blanchard; Geri Meduri; Philippe Zizzari; Martine Imbert-Teboul; Alain Doucet; Philippe Chanson; Marc Lombès
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

5.  Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.

Authors:  Say Viengchareun; Peter Kamenicky; Marie Teixeira; Daniel Butlen; Geri Meduri; Nicolas Blanchard-Gutton; Christine Kurschat; Aurélie Lanel; Laetitia Martinerie; Shoshana Sztal-Mazer; Marcel Blot-Chabaud; Evelyne Ferrary; Nadia Cherradi; Marc Lombès
Journal:  Mol Endocrinol       Date:  2009-10-21

6.  The role of a mineralocorticoid receptor gene functional polymorphism in the symptom dimensions of persistent ADHD.

Authors:  Gustavo Lucena Kortmann; Verônica Contini; Guilherme Pinto Bertuzzi; Nina Roth Mota; Diego Luiz Rovaris; Vanessa Rodrigues Paixão-Côrtes; Leandro Leal de Lima; Eugenio Horacio Grevet; Carlos Alberto Iglesias Salgado; Eduardo Schneider Vitola; Luis Augusto Rohde; Paulo Belmonte-de-Abreu; Claiton Henrique Dotto Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-15       Impact factor: 5.270

Review 7.  Nuclear receptors and AMPK: resetting metabolism.

Authors:  W Fan; M Downes; A Atkins; R Yu; R M Evans
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-03-12

8.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

Review 9.  Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere's disease.

Authors:  Nozomu Mori; Takenori Miyashita; Ryuhei Inamoto; Ai Matsubara; Terushige Mori; Kosuke Akiyama; Hiroshi Hoshikawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-01       Impact factor: 2.503

Review 10.  The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology.

Authors:  Say Viengchareun; Damien Le Menuet; Laetitia Martinerie; Mathilde Munier; Laurent Pascual-Le Tallec; Marc Lombès
Journal:  Nucl Recept Signal       Date:  2007-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.